Cornercap Investment Counsel’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Cornercap Investment Counsel’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-76,811	Closed	-$197K	–	712
2024 Q1	$197K	Hold	76,811	–	–	0.03%	567
2023 Q4	$157K	Hold	76,811	–	–	0.03%	545
2023 Q3	$132K	Sell	76,811 -1,037	-1%	-$1.84K	0.02%	525
2023 Q2	$152K	Buy	77,848 +802	+1%	+$1.88K	0.03%	534
2023 Q1	$214K	Hold	77,046	–	–	0.04%	494
2022 Q4	$266K	Hold	77,046	–	–	0.05%	480
2022 Q3	$198K	Buy	77,046 +19,359	+34%	+$61.6K	0.04%	497
2022 Q2	$140K	Buy	+57,687	New	+$152K	0.02%	511

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cornercap Investment Counsel's GRTS Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 76,811 shares — an estimated $197K sold.

Cornercap Investment Counsel first reported a position in GRTS in Q2 2022 and held it in 8 quarters. The position peaked at $266K in Q4 2022. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

Cornercap Investment Counsel reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Cornercap Investment Counsel sold 76,811 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $197K.
Cornercap Investment Counsel first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Cornercap Investment Counsel's Gritstone bio, Inc. Common Stock position peaked at $266K in Q4 2022.
79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.